by EPHA | Dec 4, 2017 | Statements
We, the undersigning organisations, active in the fields of public health and access to medicines, based in the European Union or Mercosur, draw your attention to the following: With negotiations between the European Union (EU), conducted through the European...
by European Public Health Alliance | Nov 30, 2017 | Statements
EPHA welcomes the inclusion of certain health and nutritional considerations in the European Commission’s Communication on the future of the EU Common Agricultural Policy (CAP), released yesterday. The Communication for the first time explicitly recognises that...
by European Public Health Alliance | Nov 29, 2017 | Statements
The European Consumer Organisation (BEUC), European Heart Network (EHN) and European Public Health Alliance (EPHA) publish this statement ahead of the launch of the Evolved Nutrition Label on 30 November 2017 by six food companies (Coca-Cola Company, Mars, Mondelez...
by European Public Health Alliance | Nov 28, 2017 | Statements
In 2016 at the European Commission’s Health Policy Platform, EPHA successfully pitched the idea of establishing a new Thematic Network on Antimicrobial Resistance (AMR) in order to engage a diverse group of external partners around this topic and work together on a...
by EPHA | Nov 24, 2017 | Statements
The mid-term review of the EU Roma Framework offers an opportunity to European institutions, national governments, and civil society to design a post 2020 EU Roma framework which by mainstreaming Roma Health and early childhood development ensures meaningful Roma...
by European Public Health Alliance | Nov 20, 2017 | Statements
According to the European Medicines Agency (EMA), “Scientific advice (SA) is when the Agency gives advice to a developer on the appropriate tests and studies in the development of a medicine. This is designed to facilitate the development and availability of...
